Stocklytics Platform
Asset logo for symbol HOWL
Werewolf Therapeutics
HOWL60
$1.38arrow_drop_down3.12%-$0.04
Penny Stock
Asset logo for symbol HOWL
HOWL60

$1.38

arrow_drop_down3.12%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Werewolf Therapeutics (HOWL) Stocklytics Forecast

In the world of stock market investing, it can be difficult to predict the future price of a particular stock. However, with the help of artificial intelligence and machine learning algorithms, analysts are able to make forecasts and predictions that can assist investors in making informed decisions. Werewolf Therapeutics, Inc. is a company that has been gaining attention in the biotechnology sector, and one of its stocks, HOWL, has been the center of much speculation. So, what can we expect for the future of Werewolf Therapeutics, Inc. and its stock, HOWL?
While it is important to note that no prediction or forecast can guarantee accuracy, analysts have provided some insights into the potential future of HOWL stock. According to these predictions, the stock price of Werewolf Therapeutics, Inc., HOWL, is expected to experience growth in the coming years. In particular, forecasters suggest that the stock price could see significant gains by 2023.
add Werewolf Therapeutics to watchlist

Keep an eye on Werewolf Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Werewolf Therapeutics (HOWL) stock?

Analysts have set a target price of $13.75 for Werewolf Therapeutics (HOWL), based on forecasts from 22 analysts. The predicted price range extends from a high of $28 to a low of $8.3. This represents a potential increase of up to 1.93K% and a decrease of 501.45% from the current price of $1.38. These forecasts are as of 2021 May 25.
help

What are the analyst ratings for Werewolf Therapeutics (HOWL) stock?

The analyst ratings for Werewolf Therapeutics (HOWL) are distributed as follows: 6 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Werewolf Therapeutics.
help

What is the AI price prediction for Werewolf Therapeutics (HOWL) stock?

At present, there is no AI or machine-learning-based price prediction available for Werewolf Therapeutics (HOWL) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level